首页 | 本学科首页   官方微博 | 高级检索  
检索        

灰色链霉菌RX-17溶菌酶防治龋病的实验研究
引用本文:孙继军,姜广水,张玉臻,刘浩,张晓东,卢志山.灰色链霉菌RX-17溶菌酶防治龋病的实验研究[J].山东大学学报(医学版),2005,43(5):379-381,386.
作者姓名:孙继军  姜广水  张玉臻  刘浩  张晓东  卢志山
作者单位:山东大学,腔医学院口腔内科,山东,济南,250012;山东大学,生物技术国家重点实验室,山东,济南,250100
基金项目:国家重点基础研究发展计划(2003CB716005),山东省科技攻关项目(0031301290),国家自然科学基金资助项目(30171010),国家基金项目(30470050)。
摘    要:目的:研究灰色链霉菌RX-17溶菌酶在动物口腔内对致龋菌变形链球菌的溶解作用及对龋病发生、发展的抑制作用,为将该溶菌酶用于人类龋病防治提供依据。方法:给大鼠口腔接种变形链球菌,并饲以致龋饲料2000#,分别喂以蒸馏水、氟化钠水溶液、RX-17溶菌酶液,测定牙菌斑pH值,菌斑取样、细菌培养计数,取上下颌骨进行Keyes龋齿计分。结果:RX-17溶菌酶组大鼠牙菌斑pH值高于蒸馏水组(P<0.05),低于氟化钠组(P<0.05)。变形链球菌计数在RX-17溶菌酶组少于蒸馏水组(P<0.01)和氟化钠组(P<0.05)。Keyes计分结果显示,RX-17溶菌酶组E级龋损和Ds级龋损均低于蒸馏水组(P<0.01),但与氟化钠组无差异(P>0.05)。结论:RX-17溶菌酶可以抑制大鼠口腔内变形链球菌的生长和龋病的发生、发展,其防龋效果与氟化钠相当,有可能成为一种新的防龋药物。

关 键 词:龋齿  微生物溶菌酶  变形链球菌
文章编号:1671-7554(2005)05-0379-03

Inhibitory effect of a bacteriolytic enzyme derived from streptomyces griseus RX-17 on cariogenicity in rats
SUN Ji-jun,JIANG Guang-shui,ZHANG Yu-zhen,LIU Hao,ZHANG Xiao-dong,LU Zhi-shan.Inhibitory effect of a bacteriolytic enzyme derived from streptomyces griseus RX-17 on cariogenicity in rats[J].Journal of Shandong University:Health Sciences,2005,43(5):379-381,386.
Authors:SUN Ji-jun  JIANG Guang-shui  ZHANG Yu-zhen  LIU Hao  ZHANG Xiao-dong  LU Zhi-shan
Institution:SUN Ji-jun1,JIANG Guang-shui1,ZHANG Yu-zhen2,LIU Hao1,ZHANG Xiao-dong2,LU Zhi-shan1
Abstract:Objective: To investigate the effect of RX-17 bacteriolytic enzyme derived from streptomyces griseus on the growth of a cariogenic microbe streptococcus mutans and the development of caries in rats. Methods: Wistar rats were fed with cariogenic forage 2000# and orally infected with streptococcus mutans. The rats were divided into 3 groups and administered with distilled water,sodium fluoride and RX-17 bacteriolytic enzyme, respectively, then the plague pH, germiculted plague bacteria, and obtained jaws were measured for evaluating caries scores by Keyes method. Results: Plague pH of RX-17 bacteriolytic enzyme group was significantly higher than that of distilled water group(P<0.05),but lower than that of sodium fluoride group(P<0.05). The number of streptococcus mutans was significantly less in RX-17 bacteriolytic enzyme group than in both distilled water group and sodium fluoride group (P<0.01 and P<0.05). According to Keyes scores, the number of RX-17 bacteriolytic enzyme group at E and DS levels was significantly less than that of distilled water group (P<0.01), but had no significant difference with that of the sodium fluoride group(P>0.05). Conclusions: RX-17 bacteriolytic enzyme can inhibit the growth of streptococcus mutans and the development of caries, as the sodium fluoride does. RX-17 bacteriolytic enzyme may be used as a novel anti-caries agent.
Keywords:Caries  Microbial bacteriolytic enzyme  Streptococcus mutans
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号